APP and Alzheimer disease: A separate group of investigators examined the macrophage response to lateral FPI in the R1.40 mouse model of AD, which maintains genetic predisposition to developing Aβ deposits between 12 and 15 months of age via multiple copies of the mutant APP yeast artificial chromosome (38).